Alkermes plc - Ordinary Shares (NQ:ALKS)

45.50 +0.13 (+0.29%)

Delayed Quote Updated: 10:43 AM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Alkermes plc - Ordinary Shares

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022 ↗

November 03, 2022

Upgrades

Via Benzinga

Alkermes Plans Separating Its Oncology Unit; Lifts FY22 Earnings Guidance ↗

November 02, 2022

Via Benzinga

Recap: Alkermes Q3 Earnings ↗

November 02, 2022

Alkermes (NASDAQ:ALKS) reported its Q3 earnings results on Wednesday, November 2, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Alkermes missed estimated...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022 ↗

October 14, 2022

Upgrades

Via Benzinga

Recap: Alkermes Q2 Earnings ↗

July 27, 2022

Alkermes (NASDAQ:ALKS) reported its Q2 earnings results on Wednesday, July 27, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Domino's Pizza To Rally 20%? Here Are 5 Other Price Target Changes For Friday ↗

October 14, 2022

Wedbush raised Domino's Pizza, Inc. (NYSE: DPZ) price target from $370 to $400. Wedbush analyst Nick Setyan maintained an Outperform rating on the stock. Domino's shares rose 10.4% to close at $333.26...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2022 ↗

August 16, 2022

Via Benzinga

Looking Into Alkermes's Return On Capital Employed ↗

July 28, 2022

According to data from Benzinga Pro, during Q2, Alkermes's (NASDAQ:ALKS) reported sales totaled $276.22 million. Despite a 16.06% increase in earnings, the company posted a loss of $30.14 million.

Via Benzinga

Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy ↗

July 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Preview: Alkermes ↗

July 26, 2022

Alkermes (NASDAQ:ALKS) is set to give its latest quarterly earnings report on Wednesday, 2022-07-27. Here's what investors need to know before the announcement. Analysts estimate that Alkermes will...

Via Benzinga

Biotech Hasn't Been This Blazing Hot Since Early 2021 — Here Are The Top 5 ↗

July 15, 2022

The group has several commonalities, including strong ratings and promising charts.

Via Investor's Business Daily

Sarissa Capital Comments on Alkermes Annual Meeting

July 06, 2022

From Sarissa Capital Management LP

Via Business Wire

Northrop Grumman Leads 5 Defensive Plays Near Buy Points ↗

July 02, 2022

Northrop headlines 5 stocks near buy points with the mettle to withstand a recession.

Via Investor's Business Daily

Day One Biopharmaceuticals Stock Scores Rising Relative Strength Upgrade ↗

June 15, 2022

Day One Biopharmaceuticals stock, which saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, rising from 83 to 92.

Via Investor's Business Daily

4 Biotech Stocks With Bright Prospects To Buy Amid Recovery ↗

June 11, 2022

New drug approvals, acquisitions, and other pipeline developments are back in the spotlight in the biotech industry, following the focus on the development of vaccines and antibody treatments for...

Via Talk Markets

Alkermes Announces 2022 Alkermes Inspiration Grants® Program to Support Innovative Programs Focused on People Affected by Addiction, Serious Mental Illness or Cancer

June 06, 2022

SOURCE: Alkermes

Via 3BL Media

Small-Cap Psychedelic Play Vying for Future Leadership in Addiction Treatment (AXSM, AWKNF, BICX, OPNT, ALKS, PFE, AMPH, OMER)

June 06, 2022

Via AB Newswire

The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More ↗

June 05, 2022

Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended.

Via Benzinga

Best Stocks To Buy Now: June 02, 2022

June 02, 2022

The stock market continues to be one of the best ways for regular investors to build wealth over time. The

Via Best Stocks

Topics Artificial Intelligence Cannabis

Sarissa Condemns Poor Corporate Governance at Alkermes

May 27, 2022

From Sarissa Capital Management LP

Via Business Wire

New Findings About Life With Bipolar 1 Disorder

May 27, 2022

SOURCE: Alkermes

Via 3BL Media

Global Central Nervous System Treatment Market Is Expected to Reach $166 Billion In 2028

May 26, 2022

Palm Beach, FL – May 26, 2022 – FinancialNewsMedia.com News Commentary – Worldwide, there is a rapid increase in the prevalence and incidence of neurological disorders such as multiple sclerosis,...

Via FinancialNewsMedia

Treating Bipolar 1 Disorder

May 24, 2022

SOURCE: Alkermes

Via 3BL Media

Top Biotech Stocks: Trading Opportunities For Next Week - Sunday, May 22 ↗

May 22, 2022

A security pattern traces the distinct movements of security prices that, once recognized, help traders to make informed trading decisions. Let's look at some biotech stock opportunities by analyzing...

Via Talk Markets

Alkermes Awarded 2022 Platinum Bell Seal for Workplace Mental Health

May 19, 2022

SOURCE: Alkermes

Via 3BL Media

Tips to Improve Mental Well-Being

May 17, 2022

SOURCE: Alkermes

Via 3BL Media

Alkermes Celebrates National Women's Health Week by Reminding You Why Regular Cancer Screenings Are Vital

May 13, 2022

SOURCE: Alkermes

Via 3BL Media

Alkermes to Highlight Data Related to Psychiatry Portfolio at Upcoming Scientific Conferences During Mental Health Awareness Month

May 06, 2022

SOURCE: Alkermes

Via 3BL Media

Looking Into Alkermes's Return On Capital Employed ↗

April 28, 2022

Benzinga Pro data, Alkermes (NASDAQ:ALKS) reported Q1 sales of $278.55 million. Earnings fell to a loss of $35.90 million, resulting in a 4212.6% decrease from last quarter.

Via Benzinga

61 Biggest Movers From Yesterday ↗

April 28, 2022

Gainers Vivakor, Inc. (NASDAQ: VIVK) shares jumped 113.5% to close at $3.65 on Wednesday after the company announced it has signed a 10-year contract with Hot Oil Transport with...

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.